Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rink-Jan Lohman

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Neurobiology of Disease|March 4, 2008
Protease-activated receptor-2 regulates trypsin expression in the brain and protects against seizures and epileptogenesisRink-Jan Lohman, Terence J O'Brien, Thomas M Cocks
Journal of Neuroscience Methods|August 2, 2005
Validation of a method for localised microinjection of drugs into thalamic subregions in rats for epilepsy pharmacological studiesRink-Jan Lohman, Lige Liu, Margaret Morris, et al.
Neurobiology of Learning and Memory|May 5, 2009
A regulatory role for protease-activated receptor-2 in motivational learning in ratsRink-Jan Lohman, Nigel C Jones, Terence J O'Brien, et al.
Organic Letters|November 8, 2012
Total synthesis, structure, and oral absorption of a thiazole cyclic peptide, sanguinamide ADaniel S Nielsen, Huy N Hoang, Rink-Jan Lohman, et al.
Frontiers in Pharmacology|March 20, 2023
Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapyRink-Jan Lohman, Karnaker Reddy Tupally, Ajit Kandale, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 2016
An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in MiceAnh Do, Robert C Reid, Rink-Jan Lohman, et al.
Chemical Communications (Cambridge, England)|October 22, 2019
Mirror image pairs of cyclic hexapeptides have different oral bioavailabilities and metabolic stabilitiesRink-Jan Lohman, Daniel S Nielsen, W Mei Kok, et al.
Molecular Pharmaceutics|September 23, 2022
Fabrication and Characterization of Clozapine Nanoemulsion Sol-Gel for Intranasal AdministrationMadeleine S A Tan, Preeti Pandey, Rink-Jan Lohman, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2011
Antagonism of protease-activated receptor 2 protects against experimental colitisRink-Jan Lohman, Adam J Cotterell, Jacky Suen, et al.
Chembiochem : a European Journal of Chemical Biology|September 5, 2015
Flexibility versus Rigidity for Orally Bioavailable Cyclic HexapeptidesDaniel S Nielsen, Rink-Jan Lohman, Huy N Hoang, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Neurobiology of Disease|March 4, 2008
Protease-activated receptor-2 regulates trypsin expression in the brain and protects against seizures and epileptogenesisRink-Jan Lohman, Terence J O'Brien, Thomas M Cocks
Journal of Neuroscience Methods|August 2, 2005
Validation of a method for localised microinjection of drugs into thalamic subregions in rats for epilepsy pharmacological studiesRink-Jan Lohman, Lige Liu, Margaret Morris, et al.
Neurobiology of Learning and Memory|May 5, 2009
A regulatory role for protease-activated receptor-2 in motivational learning in ratsRink-Jan Lohman, Nigel C Jones, Terence J O'Brien, et al.
Organic Letters|November 8, 2012
Total synthesis, structure, and oral absorption of a thiazole cyclic peptide, sanguinamide ADaniel S Nielsen, Huy N Hoang, Rink-Jan Lohman, et al.
Frontiers in Pharmacology|March 20, 2023
Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapyRink-Jan Lohman, Karnaker Reddy Tupally, Ajit Kandale, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 2016
An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in MiceAnh Do, Robert C Reid, Rink-Jan Lohman, et al.
Chemical Communications (Cambridge, England)|October 22, 2019
Mirror image pairs of cyclic hexapeptides have different oral bioavailabilities and metabolic stabilitiesRink-Jan Lohman, Daniel S Nielsen, W Mei Kok, et al.
Molecular Pharmaceutics|September 23, 2022
Fabrication and Characterization of Clozapine Nanoemulsion Sol-Gel for Intranasal AdministrationMadeleine S A Tan, Preeti Pandey, Rink-Jan Lohman, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2011
Antagonism of protease-activated receptor 2 protects against experimental colitisRink-Jan Lohman, Adam J Cotterell, Jacky Suen, et al.
Chembiochem : a European Journal of Chemical Biology|September 5, 2015
Flexibility versus Rigidity for Orally Bioavailable Cyclic HexapeptidesDaniel S Nielsen, Rink-Jan Lohman, Huy N Hoang, et al.
Pageof 3